Sara Basbous

Most-cited papers

1. Evidence for eomesodermin‐expressing innate‐like CD8+ KIR/NKG2A+ T cells in human adults and cord blood samples

   F. Jacomet, E. Cayssials, Sara Basbous, A. Levescot +9 more

   2015European Journal of Immunology95 citations Open access

   Semantic Scholar

   Save

2. Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases

   Alice Barbarin, E. Cayssials, F. Jacomet, N. Núñez +10 more

   2017Frontiers in Immunology62 citations Open access

   Semantic Scholar

   Save

3. BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients.

   A. Levescot, S. Flamant, Sara Basbous, F. Jacomet +12 more

   2014Cancer Research47 citations Open access

   Semantic Scholar

   Save

4. Specific features of ß-catenin-mutated hepatocellular carcinomas

   Camille Dantzer, Lydia Dif, Justine Vaché, Sara Basbous +2 more

   2024British Journal of Cancer42 citations Open access

   Semantic Scholar

   Save

5. Pathophysiological functions of Rnd proteins

   Sara Basbous, R. Azzarelli, Emilie Pacary, V. Moreau

   2020Small GTPases24 citations Open access

   Semantic Scholar

   Save

6. Evidence for BCR‐ABL‐dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients

   A. Rossignol, A. Levescot, F. Jacomet, A. Robin +8 more

   2012European Journal of Immunology20 citations

   Semantic Scholar

   Save

7. The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia

   F. Jacomet, E. Cayssials, Alice Barbarin, D. Desmier +10 more

   2017Frontiers in Immunology19 citations Open access

   Semantic Scholar

   Save

8. The Rho–ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemia

   Sara Basbous, A. Levescot, Nathalie Piccirilli, F. Brizard +5 more

   2016Journal of Pathology12 citations

   Semantic Scholar

   Save

9. Loss of RND3/RHOE controls entosis through LAMP1 expression in hepatocellular carcinoma

   Sara Basbous, Lydia Dif, Camille Dantzer, Sylvaine Di-Tommaso +6 more

   2023bioRxiv10 citations Open access

   Semantic Scholar

   Save

10. Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescence

    Sara Basbous, Lisa Paysan, S. Sena, N. Allain +6 more

    2022Cancer Gene Therapy10 citations

    Semantic Scholar

    Save

11. Rnd3/RhoE expression is regulated by G‐actin through MKL1‐SRF signaling pathway

    L. Piquet, Terezinha Robbe, V. Neaud, Sara Basbous +3 more

    2018Experimental Cell Research8 citations

    Semantic Scholar

    Save

12. Abstract 6595: Extrafollicular memory-like B cell responses ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity

    Kendrick Nguyen, Monika J. Quackenbush, Georgia Lattanzi, Daniel P. Hollern +8 more

    2026Cancer Research0 citations

    Semantic Scholar

    Save

13. B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity.

    Kendrick Nguyen, Monika J. Quackenbush, Sara Basbous, Haley Rodriguez +12 more

    2026Cell Reports0 citations Open access

    Semantic Scholar

    Save

14. Wild-type and mutated ß-catenin differently repress RND3/RHOE expression in hepatocellular carcinoma

    Sara Basbous, S. Sena, Camille Dantzer, Véronique Neaud +10 more

    2025bioRxiv0 citations Open access

    Semantic Scholar

    Save

15. Neoantigens promote effective response to combinatorial immunotherapies in triple-negative breast cancer through B cells 2347

    Georgia Lattanzi, Monika J. Quackenbush, Kendrick Nguyen, Sara Basbous +3 more

    2025Journal of Immunology0 citations

    Semantic Scholar

    Save

16. Abstract 1100: Fascin-1 inhibitor decreases hepatoblastoma cells tumorigenicity via YAP 1

    Lydia Dif, Amandine Martin, Sara Basbous, Grégoire Manaud +1 more

    2024Cancer Research0 citations

    Semantic Scholar

    Save

17. Eomesodermin together with KIR/NKG2A membrane receptors and CD49d as an useful strategy to identify NK-like CD8(+) T cells with innate features in humans: focusing on cancer diseases

    A. Herbelin, E. Cayssials, F. Jacomet, N. Núñez +9 more

    2017Journal of Immunology0 citations

    Semantic Scholar

    Save

18. La voie Rho/ROCK, un nouveau mécanisme d'échappement des cellules leucémiques au contrôle de l'immunité T innée

    Sara Basbous

    20160 citations

    Semantic Scholar

    Save

19. EOMESODERMIN-EXPRESSING INNATE-LIKE CD8+ T CELLS IN HUMANS ARE IMPAIRED IN CHRONIC MYELOID LEUKEMIA PATIENTS AT DIAGNOSIS

    A. Herbelin, F. Jacomet, Emilie Cayssals, D. Desmier +9 more

    2016Journal of Immunology0 citations

    Semantic Scholar

    Save

20. The DH/PH domain of BCR-ABL mediates INKT cell immunosubversion in chronic myeloid leukemia by downregulating cell-surface CD1D expression in myeloid dendritic cells (TUM10P.1038)

    A. Herbelin, Sara Basbous, Anais Levescot, Nathalie Piccirilli +1 more

    2015Journal of Immunology0 citations

    Semantic Scholar

    Save

21. Identification of eomesodermin-expressing innate-like T cells in adult humans (P1436)

    J. Gombert, F. Jacomet, Sara Basbous, Anais Levescot +6 more

    2013Journal of Immunology0 citations

    Semantic Scholar

    Save

22. Bcr/Abl-induced deregulation of the IL-33/ST2 pathway in CD34(+) progenitors from chronic myeloid leukemia patients (P6284)

    J. Gombert, A. Levescot, S. Flamant, F. Jacomet +9 more

    2013Journal of Immunology0 citations

    Semantic Scholar

    Save

23. Evidence for a BCR-ABL-induced anergic state of iNTK cells in chronic myeloid leukemia patients at diagnosis (162.32)

    Anais Levescot, A. Rossignol, F. Jacomet, A. Robin +8 more

    2012Journal of Immunology0 citations

    Semantic Scholar

    Save